-
Featured
IMPACT: A Standardized Tool for Assessment of Pelvic Floor Disorders
A consortium of professional societies caring for patients with different pelvic floor disorders (PVD) has reached consensus on standardized measures for initial assessment of the most commonly reported symptoms of PVDs.
-
Heartburn & COVID-19: A Q&A With Kyle Staller, MD, MPH, on Proton Pump Inhibitors and Patient Risk
Recent headlines highlight survey findings indicating an increased risk of COVID-19 among Proton Pump Inhibitors users. In this Q&A, Kyle Staller, MD, MPH, disambiguates fact from hyperbole about the COVID-19–heartburn connection.
-
Review: Imaging of Drug Mules
Radiologists may be called on to examine people suspected of concealing drugs in the GI tract, rectum or vagina. Rhea Malhotra, MD, and Ajay Singh, MD, MBBS, of the Department of Radiology, review approaches for protecting these individuals from complications and preventing the release of contraband into the community.
-
Whole-Kidney Radiomics Performs Robustly in Assessing Kidney Stones
Fatemeh Homayounieh, MD, and Mannudeep K. Kalra, MD, of the Department of Radiology, show that machine learning-based autosegmentation and radiomics can help detect and quantify kidney stone burden, assess for hydronephrosis and predict the need for invasive treatment.
-
Bowel Abnormalities and Cholestasis Are Among Radiologic Findings in COVID-19
Abdominal imaging is often performed for inpatients with COVID-19, and radiologists may be the first to detect gastrointestinal manifestations of the disease.
-
Review: Reducing the Use of Gadolinium-based Contrast Agents for Abdominal MRI in Children
Young patients are at risk of receiving multiple doses of gadolinium-based contrast agents if they need serial abdominal MRI, and radiologists should make every effort to minimize their exposure.